Posts by Cian P. McCarthy, MD
-
CAD Prevalent in Patients With Type 2 MI but Usually Non-obstructive
Cian P. McCarthy, MBBCh, BAO, SM, James L. Januzzi, Jr., MD, and colleagues found in a prospective study that coronary artery disease affected 92% of patients with type 2 myocardial infarction, but despite a large overall burden of coronary plaque, 74% did not have hemodynamically significant focal stenosis.
-
Use of High-sensitivity Cardiac Troponin Assays Would Benefit U.S. Hospitals
As of September 2021, only 33% of U.S. hospitals used high-sensitivity cardiac troponin assays, Massachusetts General Hospital researchers found. Yet, the assays are linked to modestly shorter length of stay, no increase in in-hospital mortality, and less use of invasive angiography to evaluate low-risk chest pain.
-
Type 2 Myocardial Infarction Is Prevalent in U.S., Has a Distinct Clinical Profile
Cian P. McCarthy, MD, and James L. Januzzi, Jr., MD, of the Division of Cardiology, and colleagues found in a nationwide U.S. database study that type 2 myocardial infarction (MI) is common and patients have distinctly different characteristics and outcomes than those with type 1 MI.
-
Role of Cardiologists in Evaluation of Type 2 Myocardial Infarction Unclear
Cian P. McCarthy, MB, BCh, BAO, and Jason H. Wasfy, MD, MPhil, of the Division of Cardiology, documented significant differences in testing and treatment between patients with type 2 myocardial infarction who were or were not evaluated by a cardiologist during admission, but the effect on outcomes is still unclear.
-
No Gender Differences Found in Outcomes of Type 2 MI
In the first study of its kind, cardiologists found no differences between men and women at Massachusetts General Hospital with regard to treatment strategies or short-term outcomes of type 2 myocardial infarction.
Biography
Cian P. McCarthy, MD, is a cardiologist and researcher in the Corrigan Minehan Heart Center at Massachusetts General Hospital and an instructor in Medicine at Harvard Medical School.